CRBP (STOCKS)
Corbus Pharmaceuticals Holdings, Inc.
$10.320000
+0.560000 (+5.74%)
Prev close: $9.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yuval Cohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $213.32M
- Employees
- 28
- P/E (TTM)
- -1.63
- P/B (TTM)
- 1.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.10M |
| Benefits Costs and Expenses | $107.00M |
| Costs And Expenses | $107.00M |
| Nonoperating Income/Loss | $4.97M |
| Operating Expenses | $106.88M |
| Depreciation and Amortization | $199.00K |
| Research and Development | $90.26M |
| Other Operating Expenses | $16.47M |
| Operating Income/Loss | -$106.88M |
| Income/Loss From Continuing Operations After Tax | -$101.90M |
| Income/Loss From Continuing Operations Before Tax | -$101.90M |
| Net Income/Loss | -$101.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$78.54M |
| Net Income/Loss Attributable To Parent | -$101.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$101.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.11 |
| Diluted Earnings Per Share | -$6.11 |
| Basic Average Shares | 32,433,191 |
| Diluted Average Shares | 32,433,191 |
| Assets | $126.99M |
| Current Assets | $122.75M |
| Noncurrent Assets | $4.24M |
| Fixed Assets | $71.00K |
| Other Non-current Assets | $4.16M |
| Liabilities | $24.75M |
| Current Liabilities | $21.48M |
| Accounts Payable | $5.25M |
| Wages | $2.04M |
| Other Current Liabilities | $14.19M |
| Noncurrent Liabilities | $3.27M |
| Equity | $102.24M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $102.24M |
| Liabilities And Equity | $126.99M |
| Net Cash Flow From Operating Activities | -$86.67M |
| Net Cash Flow From Operating Activities, Continuing | -$86.67M |
| Net Cash Flow From Investing Activities | $3.21M |
| Net Cash Flow From Investing Activities, Continuing | $3.21M |
| Net Cash Flow From Financing Activities | $89.35M |
| Net Cash Flow From Financing Activities, Continuing | $89.35M |
| Net Cash Flow | $5.89M |
| Net Cash Flow, Continuing | $5.89M |
| Comprehensive Income/Loss | -$101.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$101.97M |
| Other Comprehensive Income/Loss | -$68.00K |